AGA: Pause IBD Meds When Patients Have COVID-19

]]>(MedPage Today) -- Inflammatory bowel disease (IBD) patients who develop COVID-19 coronavirus infection should delay their biological therapies, restarting them once symptoms subside, said a clinical practice update from the American Gastroenterological...